- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03553134
Descriptive Study of Brain Velocity in Transcranial Doppler in Newborns Over 35 Weeks of Gestational Age in the Maternity Ward (VELOCITE)
There are significant variations in blood circulation at birth with the transition from fetal to permanent circulation. These variations are particularly impacted by the closure of the arterial canal within the first 48 hours of life.
Blood circulation velocity values within the cerebral arteries have been well documented in newborns and infants a few days old. However, the initial values of these velocities and their variations during the first hours of life are not well known.
The objective of this study is to describe the evolution of brain circulation at birth in newborns over 35 weeks of gestational age and to investigate the effect of arterial canal closure on brain circulation.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Dijon, France, 21000
- Chu Dijon Bourogne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Written consent of parent
- Newborns over 35 weeks of amenorrhoea hospitalized in the maternity ward
Exclusion Criteria:
- person not affiliated to a health insurance scheme
- Sepsis
- Ductal dependent heart disease
- Neurological impairment (anoxoischemic encephalopathy Sarnat>1, pH<7 and/or lactates>11, meningitis)
- Obstetrical trauma (instrumental delivery by forceps, vacuum cup or spatulas)
- Potentially lethal malformation
- Anemia (hemoglobin<14g/dl)
- Polyglobulia (hemoglobin>22g/dl)
- Small for gestational age (weight<10th percentile)
- Large for gestational age (weight>97th percentile)
- Proven gestational diabetes (non-insulin-dependent and insulin-dependent)
- Maternal medical treatment (cardiac or anti-epileptic)
- Inadequate parent understanding
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Right and left average velocity of the cerebral artery
Time Frame: Change from birth to 48 hours of life
|
Change from birth to 48 hours of life
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LITZLER-RENAULT 2018 VELOCITE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.